Hovione And Merrion Pharmaceuticals, Inc. Announce Strategic Partnership On Use Of Merrion’s GIPET Technology

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LISBON, Portugal, July 15, 2014 /PRNewswire/ --

Hovione and Merrion Pharmaceuticals [ESM; MERR] announced today that they have concluded a strategic partnership directed to the use of Merrion’s patented GIPET absorption enhancing technology by Hovione clients. Hovione, an international contract formulation and manufacturing group, will add its commercial reach and technical expertise to generate new products where the use of absorption enhancement through GIPET is appropriate.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC